Centessa Pharmaceuticals Files Mixed Shelf; Launches $150 Million Offering of American Depositary Shares

MT Newswires Live09-12

Centessa Pharmaceuticals (CNTA) on Wednesday filed a registration statement covering the potential sale of its securities from time to time.

The filing covers ordinary shares, American depositary shares, debt securities, warrants, and units.

Net proceeds will be primarily for general corporate purposes, the company said, adding it may also use part of the proceeds to pay interest or principal on debt and/or buy and invest in companies, products and technologies.

Separately, Centessa said Wednesday it has started an underwritten public offering of $150 million of American depositary shares.

The company said it plans to give the underwriters a 30-day option to buy up to an additional $22.5 million of ADSs.

The planned offering is subject to market conditions, and there's no assurance as to whether or when it may be completed, or as to its size or terms, Centessa added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment